Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01770951 · ClinicalTrials.gov registry record
A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
A clinical trial, sponsored by Alexion Pharmaceuticals.
- Completed
- Registry status
- 30
- Enrollment target
NCT01770951 is a clinical trial that has completed, run by Alexion Pharmaceuticals. The registered enrollment target is 30 participants.
The verdict
NCT01770951 has completed, sponsored by Alexion Pharmaceuticals.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The objective of this retrospective trial is to assess safety and efficacy of eculizumab in aHUS patients treated outside of an Alexion-sponsored controlled clinical trial.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-08-31 |
| Est. Completion | 2010-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01770951
The ClinicalTrials.gov registry entry for NCT01770951 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexion Pharmaceuticals, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01770951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01770951 about?
NCT01770951 is a clinical study titled "A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)". The objective of this retrospective trial is to assess safety and efficacy of eculizumab in aHUS patients treated outside of an Alexion-sponsored controlled clinical trial.
What is the current status of trial NCT01770951?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-08-31. Estimated completion is 2010-11-30.
Who is sponsoring clinical trial NCT01770951?
This trial is sponsored by Alexion Pharmaceuticals, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.